Agreement - April 10, 2019
Genovis collaborates with Thermo Fisher Scientific
The two companies have entered into a collaboration agreement to develop advanced end-to-end workflows for the preparation, characterization and monitoring of novel and complex biotherapeutics using liquid chromatography-mass spectrometry (LC-MS). The collaborative partnership aims to develop advanced end-to-end methods for the analysis of novel and complex biotherapeutics to meet the increasing demands for high throughput, […]
Drug development - August 16, 2013
Genovis evaluates new diagnosis technology
Genovis has signed an agreement with Respiratorius to evaluate a new technology for the early diagnosis of cardiovascular disease. The agreement involves tests and evaluation of RESP-3000 as a new biomarker for early diagnosis of cardiovascular disease using PET-imaging. The final evaluation will be conducted by GeccoDots AB, Genovis’ wholly owned subsidiary. According to a […]
Agreement - March 27, 2013
Genovis in new agreement
Swedish Genovis AB recently announced the signing of a new agreement with a major pharmaceutical company. Genovis has not revealed the name of the new business partner but announces that the one-year development project agreement is worth approximately 100 000 US dollars. The project will adapt their products from the protein characterization portfolio to the […]
